Related Experiment Video
Updated: Jul 10, 2026
15:04
Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation
Published on: January 19, 2019
Topotecan in cervical cancer.
S Ackermann1, M W Beckmann, F Thiel
1Department of Gynecology and Obstetrics, Universitätsklinikum Friedrich-Alexander University, Erlangen-Nürnberg, Germany. ackermann@gyn.imed.uni-erlangen.de
Summary
Topotecan shows promise for treating advanced cervical cancer, improving survival rates when combined with chemotherapy. This review highlights its potential as a new standard of care for recurrent or advanced cases.
Area of Science:
- Gynecologic Oncology
- Medical Oncology
- Clinical Trials
Background:
- Recurrent and advanced cervical cancer present significant treatment challenges with high mortality.
- Effective options are limited, particularly for patients unsuitable for surgery or radiation.
- Topotecan demonstrates broad efficacy and manageable toxicity in other cancers.
Purpose of the Study:
- To systematically review studies evaluating topotecan in cervical cancer treatment.
- To assess topotecan's effectiveness as a single agent and in combination therapies.
- To evaluate topotecan's role in induction therapy with radiotherapy.
Main Methods:
- Systematic review of seven phase I-III clinical trials.
- Inclusion of studies using topotecan alone or with cisplatin/paclitaxel.
- Evaluation of data from two studies involving topotecan with radiotherapy.
Main Results:
- Topotecan combined with cisplatin and/or radiation therapy yields high objective response rates.
- Gynecologic Oncology Group (GOG) Protocol 179 demonstrated improved survival with topotecan combination therapy versus cisplatin alone.
- Topotecan shows potential to become a new standard of care for advanced cervical cancer.
Conclusions:
- Topotecan, particularly in combination with cisplatin, offers a promising treatment for recurrent or advanced cervical cancer.
- Further research is ongoing to compare topotecan combinations with existing standards.
- Topotecan warrants further investigation in neoadjuvant settings and with novel biologic agents.
Related Concept Videos
01:15Drugs that Stabilize Microtubules
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
01:27Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...